Among the 99 RT-PCR negative patients, the BioMedomics and ACE Biolabs anti-COVID-19 IgM and IgG assays were negative in 95.96% (95/99) and 97.98% (96/99) of samples, respectively (Table 3). This evidence concerns the gene CD40LG and COVID-19.